OD

 Southern California College of Optometry Celebrates 120 Years of Educational and Clinical Excellence

Retrieved on: 
Wednesday, April 3, 2024
Education, Health, Research, Science, University, Optical, Psychiatry, MBKU, Longevity, Accreditation Council, Specialization, Learning, Mentorship, Marshall B. Ketchum University, American Optometric Association, American Academy, Faculty, SCCO, Student, Publication, Vision science, Pharmacy, Pathology, Multimedia, AOA, OD, Accreditation, Ophthalmology, Nursing

Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution headquartered in Fullerton, Calif. proudly celebrates the 120th anniversary of its Southern California College of Optometry (SCCO) .

Key Points: 
  • Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution headquartered in Fullerton, Calif. proudly celebrates the 120th anniversary of its Southern California College of Optometry (SCCO) .
  • Since then, it has earned a reputation as one of the oldest and most esteemed optometry schools in the nation.
  • View the full release here: https://www.businesswire.com/news/home/20240403689163/en/
    Southern California College of Optometry Celebrates 120 Years (Graphic: Business Wire)
    "SCCO's 120-year journey signifies more than just longevity; it represents a commitment to best-in-class optometric education,” said Dr. Julie A. Schornack, president at MBKU.
  • As SCCO celebrates its 120-year legacy, it remains steadfast in its commitment to cultivating the leaders of tomorrow.

West Point Optical Group, LLC and Verséa Ophthalmics, Inc. Announce Partnership Supply Agreement for  BIOVANCE®and BIOVANCE® 3L Ocular

Retrieved on: 
Wednesday, April 3, 2024
Health, Optical, Surgery, WPOG, Extracellular matrix, Allotransplantation, Partnership, Patient, Wound healing, Pearle Vision, OD, Ophthalmic, Telescopic sight

BIOVANCE® and BIOVANCE® 3L Ocular, which are single-layer and three-layer (3L) allografts, respectively, are intended for use as a biological membrane covering that provides an extracellular matrix.

Key Points: 
  • BIOVANCE® and BIOVANCE® 3L Ocular, which are single-layer and three-layer (3L) allografts, respectively, are intended for use as a biological membrane covering that provides an extracellular matrix.
  • BIOVANCE® 3L Ocular is acellular and consists of three layers of amniotic basement membrane that supports treatment of advanced ocular surface disease.
  • As a barrier membrane, BIOVANCE® 3L Ocular is intended to protect the underlying tissue and preserve tissue plane boundaries.
  • “We are excited to partner with Verséa Ophthalmics allowing our eye care professionals to deliver the benefits of BIOVANCE® and BIOVANCE® 3L Ocular products to their patients,” said John Womack, OD, West Point Optical Group’s Chief Medical Officer.

Global Orphan Drug Growth Opportunities Analysis - Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 2, 2024
Health, Pharmaceutical, ODD, IRA, Data wrangling, Informatics, Growth, Patient, Public, Neoplasm, Research, Health care, Cancer, ODS, Medicine, Investment, RDS, US FDA, Nanomedicine, RD, Inflation, OD, SME, Multiomics, Pharmaceutical industry

The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • This study provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth.
  • The growing number of unaddressed RD needs is a major catalyst for R&D.
  • There is a need for novel medicine to treat RDs that currently have limited therapeutic choices.

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis

Retrieved on: 
Tuesday, March 5, 2024
Education, Inflammation, FDA, Irritation, MITES, Blepharitis, OD, Patient, Disease, Eyelid, Diagnosis, Science, Infestation, Human, TARS, Pharmaceutical industry

“Mite Party” is designed to elevate consumer awareness of Demodex blepharitis through relatable messaging and compelling visuals to encourage patients who may have Demodex blepharitis to seek out an eye care provider for screening.

Key Points: 
  • “Mite Party” is designed to elevate consumer awareness of Demodex blepharitis through relatable messaging and compelling visuals to encourage patients who may have Demodex blepharitis to seek out an eye care provider for screening.
  • “We are committed to increasing Demodex blepharitis education and awareness so that patients more effectively understand their disease and are motivated to seek treatment,” said Aziz Mottiwala, Chief Commercial Officer of Tarsus.
  • We look forward to advancing this novel campaign with the goal of helping as many patients with Demodex blepharitis as possible.”
    Demodex blepharitis occurs when Demodex mites – the most common ectoparasites found on humans – overpopulate on the eyelids.
  • “Mite Party” will officially launch on the XDEMVY Facebook page (@xdemvyrx) with a live event designed to “break up the mite parties” on Demodex blepharitis patients’ eyelids.

AllBright Alliance Welcomes Industry Powerhouses—British Airways, Guggenheim Investments and Tapestry (Coach, Kate Spade, Stuart Weitzman)—as It Marks a Year of Substantial Growth and Gender Equity Impact

Retrieved on: 
Friday, March 8, 2024
Professional Services, Thought Leadership, Business, Training, Consumer, Asset Management, DEI (Diversity, Equity and Inclusion), Education, Women, Human Resources, Finance, Environmental, Social and Governance (ESG), Consulting, Woman, BNY Mellon, Workplace, Soho House, AllBright Law Offices, Growth, Female, Guggenheim Partners, Mentorship, Corporate Affairs, OD, Eldridge Industries, Chelsea F.C., Gender, HSBC, Research

The milestone comes one year after the programme's inception, highlighting a period of significant growth and impact in supporting gender equity across the world.

Key Points: 
  • The milestone comes one year after the programme's inception, highlighting a period of significant growth and impact in supporting gender equity across the world.
  • With the addition of these new partners, AllBright Alliance now reaches over 750,000 employees across various sectors.
  • “We are thrilled to be partnering with AllBright, underscoring our significant commitment to strengthening gender equality in the workplace,” said Dina DiLorenzo, Co-President of Guggenheim Investments.
  • This helps us become a more sustainable organisation and further reduce our gender pay gap.”
    For more information on AllBright Alliance visit www.allbrightcollective.com/business ; or for interview/ further commentary, contact [email protected]

SightMD Welcomes Cynthia Zara, OD to its expert team in New York

Retrieved on: 
Monday, March 4, 2024
Diabetes, Ophthalmology, Food Network, Infection, Eye, Floater, Southern College of Optometry, Volunteering, State university system, School, Contact, Macular degeneration, Chalazion, OD, Patient, Glasses, Risk, Glaucoma, Food, Whaling

HAUPPAUGE, N.Y., March 4, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.
  • HAUPPAUGE, N.Y., March 4, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.
  • Cynthia Zara, OD is a board-certified optometrist providing dilation exams, contact lenses and eyeglasses, dry eye treatments, and more.
  • When asked what she is looking forward to most about joining the SightMD Team, Dr Zara said "I am excited to be joining SightMD in Hamptons Bays and Southampton.

CathSOLVER™ simplifies MicroCatheter Design Development

Retrieved on: 
Friday, March 1, 2024
Software, SAN, EI, Torque, Multimedia, ID, Stiffness, User, Ultimate tensile strength, OD, Flexural rigidity, Artificial intelligence

SAN ANTONIO, Feb. 29, 2024 /PRNewswire-PRWeb/ -- Roth Technologies, LLC announces the immediate release of the CathSOLVER™ function add-in for the CathCAD® Standard software for all licensed Users.

Key Points: 
  • CathCAD® modernized the microcatheter design process in 2012 by solving the forward problem catheter design problem numerically, that is, given the geometry and the physical characteristics of the design, the Software computed the functional characteristics of the design including longitudinal rigidity, flexural rigidity, torsional rigidity, kink radius, and the applicable failure modes.
  • CathSOLVER™ solves the inverse catheter design problem, that is, given a set of desired characteristics (ID, OD, number of layers, and desired physical attributes), the Software will compute and provide the "best" design that meets the catheter design requirements.
  • When the applicable design parameters are fully developed by the User, the CathSOLVER™ algorithm executes hundred of designs iterations resulting in the Software determining the best design given the User's defined constraints.
  • When the applicable design parameters are fully developed by the User, the CathSOLVER™ algorithm executes hundred of designs iterations resulting in the Software determining the best design given the User's defined constraints.

Foundation Fighting Blindness Hosting Webinar for Eye Care Professionals: Best Clinical Practices for Patients with Inherited Retinal Diseases

Retrieved on: 
Tuesday, February 13, 2024
Therapy, Retinitis pigmentosa, Leber congenital amaurosis, Caregiver, Doctor of Philosophy, Ear, SCCO, University of Iowa, MD, Optometry, Brain damage, Genetic testing, University, Foundation Fighting Blindness, Visual impairment, Stargardt disease, Genetics, OD, Patient, IRD, Rehabilitation, Harvard Medical School, Marshall B. Ketchum University, Science, Usher syndrome, Research, Acquired brain injury, Nursing

COLUMBIA, Md., Feb. 13, 2024 /PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host a webinar for eye care professionals on the best practices for managing their patients with inherited retinal diseases (IRDs), including retinitis pigmentosa, Usher syndrome, Stargardt disease, and Leber congenital amaurosis. This webinar will be a part of the March Envisioning a Path to Hope initiative, raising awareness among eye care professionals for the valuable resources the Foundation provides IRD patients and caregivers.

Key Points: 
  • This webinar will be a part of the March Envisioning a Path to Hope initiative, raising awareness among eye care professionals for the valuable resources the Foundation provides IRD patients and caregivers.
  • "With nearly 50 clinical trials underway for emerging IRD therapies and no-cost genetic testing available for patients, eye care professionals can do so much to help IRD patients on their challenging journeys," says Michelle Glaze, director of professional outreach, Foundation Fighting Blindness.
  • "We are delighted to host this informative webinar to empower eye doctors to communicate hope and a path forward for their IRD patients and families."
  • She treats patients in the clinical departments of Acquired Brain Injury and Low Vision Rehabilitation, where she also conducts genetic testing for inherited eye conditions.

OCLI Vision Welcomes Dr. Kinnari Patel, OD, to the Northeast Philadelphia, Pennsylvania Area to Expand Access to Great Eye Care in the Region

Retrieved on: 
Monday, February 5, 2024
Gettysburg College, Knowledge, University, Glaucoma, AMD, OD, Patient, Central Florida, Health, Optometry, Macular degeneration, Telecanthus, Diabetic retinopathy, Telescopic sight

GARDEN CITY, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- OCLI Vision is thrilled to announce the latest addition to our team, Dr. Kinnari Patel, OD, who will be exclusively serving the Northeast Philadelphia location starting February 5th, 2024.

Key Points: 
  • Dr. Patel, a highly accomplished optometrist, brings over a decade of experience and expertise in primary eye care.
  • "I am delighted to join OCLI Vision team, where I can leverage my decade-long experience to provide outstanding eye care to patients.
  • I provide patient care for all aspects of primary eye care with focus on Dry Eye and Ocular Surface Disease."
  • I provide patient care for all aspects of primary eye care with focus on Dry Eye and Ocular Surface Disease.

Eye Health America Announces Newest Acquisition of Loris Eye Associates

Retrieved on: 
Thursday, February 1, 2024
Optical, Health, Surgery, Practice Management, Partnership, Contact, Southeastern United States, Associate, MD, Glaucoma, LEA, OD, Patient, Pediatrics, Retina, CCFS, Abdominal ultrasonography, Physician, EHA, Hospital

Welcome Dr. Tracy Ray and Loris team to our exceptional roster of eye care professionals.

Key Points: 
  • Welcome Dr. Tracy Ray and Loris team to our exceptional roster of eye care professionals.
  • Founded in 2018 by LLR Partners, Clemson Eye, and The Eye Associates, EHA is led by experienced eye care leadership, providing superior support to partner practices.
  • Eye Health America (EHA) is a leading eyecare provider focused on partnering with culturally aligned ophthalmology practices, optometry practices and ambulatory surgery centers across the Southeast U.S. to provide superior strategic, financial, and operational support for best-in-class eye care.
  • Member practices include Clemson Eye, Piedmont Surgery Center, EHA Surgery Center Seneca, The Surgery & Laser Center, Carolinas Centers for Sight, Florence Surgery and Laser Center, Southeast Retina Center, Augusta Retina Laser Surgicare, The Eye Associates, The Eye Associates Surgery Center, EHA Surgery Center Sarasota, Eye Centers of Florida, Surgicare Center, Updegraff Laser Vision, Tampa Bay Eye Surgery Center, West Georgia Eye Care Center, Eye Surgery Center of West Georgia, and many other top eyecare providers.